SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-23-016878
Filing Date
2023-05-09
Accepted
2023-05-09 16:57:13
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 prtk-sx3.htm S-3 322160
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 35865
3 EX-4.3 exhibit43-sx3.htm EX-4.3 347598
4 EX-5.1 exhibit51-sx3.htm EX-5.1 19718
5 EX-23.1 exhibit231-sx3.htm EX-23.1 3195
6 EX-25.1 exhibit251-sx3.htm EX-25.1 129820
7 image_1a.jpg GRAPHIC 373476
8 parateklogo.jpg GRAPHIC 34386
9 ropesgraya.jpg GRAPHIC 45811
  Complete submission text file 0001628280-23-016878.txt   1482610
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271780 | Film No.: 23903073
SIC: 2834 Pharmaceutical Preparations